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Abstract
Background: Drug prescription practices depend on several factors related to the patient, health worker and health
facilities. A better understanding of the factors influencing prescription patterns is essential to develop strategies to
mitigate the negative consequences associated with poor practices in both the public and private sectors.
Methods: A cross-sectional study was conducted in rural Tanzania among patients attending health facilities, and
health workers. Patients, health workers and health facilities-related factors with the potential to influence drug
prescription patterns were used to build a model of key predictors. Standard data mining methodology of
classification tree analysis was used to define the importance of the different factors on prescription patterns.
Results: This analysis included 1,470 patients and 71 health workers practicing in 30 health facilities. Patients were
mostly treated in dispensaries. Twenty two variables were used to construct two classification tree models: one for
polypharmacy (prescription of ≥3 drugs) on a single clinic visit and one for co-prescription of
artemether-lumefantrine (AL) with antibiotics. The most important predictor of polypharmacy was the diagnosis
of several illnesses. Polypharmacy was also associated with little or no supervision of the health workers,
administration of AL and private facilities. Co-prescription of AL with antibiotics was more frequent in children
under five years of age and the other important predictors were transmission season, mode of diagnosis and the
location of the health facility.
Conclusion: Standard data mining methodology is an easy-to-implement analytical approach that can be useful for
decision-making. Polypharmacy is mainly due to the diagnosis of multiple illnesses.
Keywords: Polypharmacy, Co-prescription, Anti-malarials, Classification trees, Data mining, Tanzania
Background
Irrational drug use or misuse means the distribution or
consumption of drugs in ways that negate or reduce
their efficacy or in situations where they are unlikely to
have the desired effect [1]. Besides being an economic
burden for the patients, communities and health sys-
tems, it may result in drug resistance, ineffective treat-
ment and adverse drug events. According to the World
Health Organization (WHO) the ‘rational use of drugs
requires that patients receive medications appropriate to
their clinical needs, in doses that meet their own individ-
ual requirements for an adequate period of time, and at
the lowest cost to them and their community’ [2]. Ir-
rational drug use is a widespread practice in developing
counties [3], though it occurs in high-income countries,
e g, antibiotics [4,5].
Tanzania revised its malaria treatment policy in 2006
and replaced sulphadoxine-pyrimethamine (SP) with
artemether-lumefantrine (AL) as first-line treatment for
uncomplicated malaria [6], complying with the WHO
guidelines [7]. Such policy change was necessary because
of the decreasing efficacy of SP [6]. The success of a new
treatment policy partly depends on the compliance of
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prescribers’ to the national guidelines and on the
patients’ adherence to the treatment [8]. Irrational treat-
ment practices are more common in the private than in
the public sector and in most developing countries the
private sector manages over half of all malaria cases [9].
Prompt and effective treatment of malaria patients is
one of the cornerstones of the global efforts to reduce
malaria morbidity and mortality. As many countries in
sub-Saharan Africa are introducing relatively expensive
artemisinin-based combination therapy (ACT) into the
formal health system for uncomplicated malaria, policy
makers, programme managers and donors are interested
in assessing the quality of malaria case management with
ACT, in particular ensuring that malaria patients are ap-
propriately treated with an ACT [10].
The INDEPTH effectiveness and safety studies of anti-
malarial drugs in Africa (INESS) project is a Phase IV
study on both existing and new combination anti-malarial
therapies in at least seven INDEPTH demographic sur-
veillance system (DSS) sites in four African countries. This
project effectively creates the missing final section of the
drug development pipeline for Africa by ensuring local
evidence on treatment effectiveness. The purpose is to
minimize the time gap between licensure and adoption of
new anti-malarials by providing objective endemic-
country effectiveness data that will help inform global and
national policy and practice. This project also enhances
the capacity of Africa to monitor local health systems
costs, effective coverage, and effects of new or alternative
post-registration anti-malarial treatments.
The health facility survey conducted as part of the
evaluation of system effectiveness of ACT, generated data
on drug prescriptions from patients and health workers in
rural health facilities, either private or public. This analysis
besides describing the drug prescription patterns illus-
trates the use of standard data mining methods of classifi-
cation tree analyses for investigating the influence specific
patient, health care provider or health facility characteris-
tics may have on drug prescription.
Methods
Study area and population
The study was conducted in March and October 2010
on patients and health workers in health facilities located
within the Rufiji and Ifakara health and demographic
surveillance system (HDSS) areas. Rufiji district in the
coast region has about 182,000 inhabitants and a HDSS
in place since 1998, covering a population of about
85,000 inhabitants [11]. The Ifakara HDSS is located in
southern Tanzania and covers two districts (Kilombero
and Ulanga) in Morogoro region, with a population of
about 99,000 people [12]. All government and non-
government health facilities providing outpatient care
within the HDSS areas were included (16 in Rufiji and
14 in Ifakara). Investigators visited each facility for two
to three days and collected information on attending
patients. The target sample size was 720 patients per
HDSS to estimate the proportion of those with uncom-
plicated malaria correctly treated with an ACT with 10%
precision, assuming these represented 20% of all
patients, that 75% of malaria patients would be treated
with an ACT, and a design effect of 2. All patients
attending for illness the health facilities on the days of
the survey were eligible. Health workers were following
the national guidelines for diagnosis and treatment of
malaria.
Data collection
After providing their consent to be included in the sur-
vey, patients were interviewed prior to leaving the health
facility using standardized questionnaires developed in
English and translated into Kiswahili. Information on
history of fever, health worker’s diagnoses, laboratory
tests, medications prescribed and counselling messages
was collected. Pregnant patients were excluded from the
survey. Health workers providing outpatient consulta-
tions were also interviewed on pre-service training, work
experience, in-service training and supervision visits
received. Assessment of the level of staffing, availability
of diagnostics, medications and other medical supplies
was done at the health facility. A list of variables used in
the analysis is shown in Table 1.
Data management and analysis
Data were double entered and validated using EpiData
3.1 [13], cleaned, managed and analysed using STATA
11[14] and SPSS [15]. Measures for central tendency
and dispersion used to describe these data were mean
and 95% confidence intervals for continuous variables
and percentages for categorical variables. The popula-
tion was first described on demographics and other
variables of importance.
This paper describes and analyses the INESS project
health facility survey data from Tanzania. The different
methods of data analysis applied in this paper are
explained in the next section, starting from standard
data mining techniques to investigate the predictors of
polypharmacy and co-prescription of AL with an anti-
biotic at health facilities in rural Tanzania. Polypharmacy
is defined as a practice where a patient was prescribed
three or more medications at a single encounter in a
health facility or with a health worker.
Statistical methodology
Logistic regression is the standard technique used to
investigate the relationship between binary response
variables and a set of explanatory variables. However,
with the large number of explanatory variables involved,
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because of potential co-linearity and interactions, it
would be complex to investigate for each covariate the
nature of the relationship (linear, interaction terms,
quadratic, etc.). Moreover, with 22 variables there are
462 possible two-way interactions and it is not feasible
to consider all of them. For these reasons, non-
parametric classification tree modelling methodologies
were used [16-18]. A classification and regression tree
(CART) analysis is a useful nonparametric data-mining
technique. This analysis is particularly helpful when
attempting to investigate which direct and indirect
measures of risk are predictive of a newly emerging or
complex disease [17]. Contrary to classical regression
that uses linear combinations, this method does not re-
quire the data to be linear or additive. Furthermore,
classification tree analysis does not require to pre-
define possible interactions between factors [18].
Therefore, the resulting classification trees accommodate
in an intuitive manner more flexible relationships among
variables, missing covariate values, multi-colinearity, and
outliers [19]. When values for some predictive factors are
missing, they can be estimated using other predictor
(“surrogate”) variables, permitting the use of incomplete
data sets when generating regression trees [16,18]. An-
other advantage of classification tree analysis (compared
with a classical multivariate regression analysis) is that it
allows for the calculation of the overall discriminatory
power, or relative importance, of each explanatory
variable.
Classification tree modelling
To gain more insight into factors related to dependant
variables of polypharmacy (prescription of ≥3 drugs) and
co-prescription of AL with antibiotics in rural health facil-
ities, the binary classification tree modelling methodology
as introduced by Breiman [18] was used. Classification
trees are widely used in applied fields as diverse as
Table 1 Classification tree variables
Type Variable Levels
Health
facility-related
Type of health facility Hospital
Health Centre
Dispensary
Ownership of health facility Public
Private
Any artemether lumefantrine
available in health facility today
No
Yes
Supplies to administer oral
medications available
No
Yes
Availability of any scale in the
health facility
No
Yes
No stock-outs of artemether
lumefantrine in previous 90 days
No
Yes
Health
worker-related
Mode of diagnosis Laboratory confirm
Presumptive diagnosis
Health workers' cadre Medical Officer/
Doctor
Medical Assistant/
Clinical Officer
Nurse and lower
level cadres
Health worker sex Male
Female
Health worker age Continuous variable
Patient seen by health
worker with medical training
No
Yes
Possession of national malaria
guideline
No
Yes
Possession of national malaria wall
chart
No
Yes
Patient-
related
Total number of diagnoses
presented on a single visit
Continuous variable
Age group of the patients Less than 5 yrs
5-14 yrs
15 yrs and above
Patient treated
with artemether lumefantrine
No
Yes
Patient sex Male
Female
Table 1 Classification tree variables (Continued)
Transmission season High season
Low season
Patient seen by health worker who
trained on use of new anti-malarial
No
Yes
Patient seen by experienced health
worker
No
Yes
Patient seen by health worker
supervised within previous six months
No
Yes
Patient seen by health worker with
IMCI training
No
Yes
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medicine (diagnosis), computer science (data structures),
botany (classification), and psychology (decision theory)
[18-20]. Classification trees are popular in applied fields
partly because they are agreeable to graphical display and
easy to interpret compared to the use of strict numerical
interpretation. Flexibility and hierarchical nature are two
important features characterizing classification trees.
Classification tree analysis is a nonlinear and nonpara-
metric model that is fitted by binary recursive partition-
ing of multidimensional covariate space. The analysis
successively splits the data set into increasingly homo-
geneous subsets until it is stratified to meet specified
criteria [16,18,19,21,22]. The Gini index was used as the
splitting method, and 10-fold cross-validation was used
to test the predictive capacity of the obtained trees. The
classification tree method performs cross validation by
growing maximal trees on subsets of data then calculat-
ing error rates based on unused portions of the data
set. To accomplish this, it divides the data set into 10
randomly selected and roughly equal “parts,” with each
part containing a similar distribution of data from the
populations of interest (e.g., polypharmacy vs single pre-
scription). The method then uses the first nine parts of
the data, constructs the largest possible tree, and uses
the remaining 1/10 of the data to obtain initial esti-
mates of the error rate of the selected sub-tree. The
process is repeated using different combinations of the
remaining nine subsets of data and a different 1/10 data
subset to test the resulting tree. This process is repeated
until each 1/10 subset of the data has been used as to
test a tree that was grown using a 9/10 data subset. The
results of the 10 minitests are then combined to calcu-
late error rates for trees of each possible size; these
error rates are applied to prune the tree grown using
the entire data set. The consequence of this complex
process is a set of fairly reliable estimates of the inde-
pendent predictive accuracy of the tree, even when
some of the data for independent variables are incom-
plete, specific events are either rare or overwhelmingly
frequent, or both.
For each node in a generated tree, the “primary split-
ter” is the variable that best splits the node, maximizing
the purity of the resulting nodes. When the primary
splitting variable is missing for an individual observation
that observation is not discarded but, instead, a surro-
gate splitting variable is sought. A surrogate splitter is a
variable whose pattern within the data set, relative to the
outcome variable, is similar to the primary splitter. Thus,
the program uses the best available information in the
face of missing values. In data sets of reasonable quality,
this allows all observations to be used. This is a signifi-
cant advantage over more traditional multivariate regres-
sion modeling, in which observations missing any of the
predictor variables are often discarded [17-19].
Variable relative importance ranking
One of the goals of classification tree analysis is to de-
velop a simple tree structure for predicting data, result-
ing in relatively few variables that appear explicitly as
splitters, a result that may suggest that the other vari-
ables are not important in understanding or predicting
the dependent variable. However, unlike a linear regres-
sion model, a variable in a classification tree modelling
can be considered highly important even if it never
appears as a node splitter [19,21,23,24]. Because the
method keeps track of ‘surrogate’ splits in the tree-
growing process, the contribution a variable can make in
prediction is not determined only by primary splits.
To calculate a variable importance score, the classifica-
tion tree analysis method looks at the improvement
measure attributable to each variable in its role as either
a primary or a surrogate splitter. The values of ALL
these improvements are summed over each node and to-
talled, and are then scaled relative to the best performing
variable. The variable with the highest sum of improve-
ments is scored 100, and all other variables will have de-
creasing lower scores. The importance score measures a
variable's ability to perform in a specific tree of a specific
size either as a primary splitter or as a ‘surrogate’ splitter.
The relative importance ranking of variables tends to
change dramatically when comparing trees of substan-
tially different sizes. Therefore, the importance scores
(rankings) are strictly relative to a given tree structure
and should not be interpreted as the absolute informa-
tion value of a variable.
The TREE command in SPSS [15] was used to gener-
ate the classification trees showing the classification
rules generated through recursive partitioning and rela-
tive variable importance.
Ethical clearance
The study received ethical clearance from the Ifakara
Health Institute ethical review board (IHI/IRB/No.A67-
2009) and national ethical clearance after having met the
criteria for ethical considerations.
Results
Description of patient characteristics by health facility
ownership
A total of 1,470 patients attended the outpatients depart-
ment (OPD) of health facilities, most of them (1,116, 76%)
at 18 publicly owned facilities and the rest at 12 private fa-
cilities (Table 2). More than half (53.5%) of the patients
were less than five years old and 53% were females. The
majority (71%) of patients attended OPD of a peripheral
health facility while just 2.1% that of a hospital. Laboratory
diagnosis was done in more than half of the patients
(54%), while the rest were presumptively treated by a doc-
tor and/or other clinical personnel. Laboratory tests were
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more commonly used in private (83%) than in public sec-
tor (45%) health facilities. Overall, the average number of
drugs prescribed per encounter was 2.3 (range: 1–6) per
patient, with private sector patients receiving more drugs
than those in public (2.5 vs. 2.2). Only 15% of the patients
were prescribed only one drug while 7% received more
than three drugs on one visit (Table 2).
Out of 1,470 patients interviewed, 14 did not have record
of any medication taken. Of the remaining 1,456 patients
who were prescribed at least one drug, 36.7% were pre-
scribed three or more medicines (polypharmacy). Using the
variables in Table 1 to fit the model, the most important
predictor of polypharmacy was the total number of
diagnosed illnesses at a single clinic visit – a patient-related
factor (Table 3). This was followed by a facility related fac-
tor – ownership (private/public) with discriminatory power
of 36.1%. Other factors were treating a patient with first-
line drugs (AL) with a power of 27%, health worker age
(power: 26%), a health worker being trained in IMCI with
anti-malarial components, a facility not experiencing AL
stock-out in the previous 90 days (health facility-related),
health worker gender, health worker having been super-
vised in the previous six months (power: 11.5%), the
remaining factors had<10% discriminatory power (Table 3).
Table 2 Patient characteristics by health facility ownership
Public n = 1,116 (76%) Private n = 354 (24%) Total n = 1,470
N % N % N %
Gender
Male 507 45.4 175 49.4 682 46.4
Female 609 54.6 179 50.6 788 53.6
Age groups
Less than 5 597 53.5 104 29.4 701 47.7
5 to 14 189 16.9 56 15.8 245 16.7
15 + 330 29.6 194 54.8 524 35.6
Health facility type
Dispensary 713 63.9 323 91.2 1036 70.5
Health centre 403 36.1 0 0 403 27.4
Hospital 0 0 31 8.8 31 2.1
Diagnosis mode
Laboratory confirmation 499 44.7 295 83.3 794 54.0
Presumptive 386 34.6 36 10.2 422 28.7
Missing 231 20.7 23 6.5 254 17.3
Total number of drugs taken on this visit; mean (95%CI) 2.2(2.1-2.3) 2.5(2.4-2.6) 2.3(2.2-2.3)
Number of drugs taken grouped
One 178 16.0 42 11.9 220 15.0
Two 558 50.0 143 40.4 701 47.7
Three 311 27.9 121 34.2 432 29.4
More than three 59 5.3 44 12.4 103 7.0
Missing 10 0.9 4 1.1 14 0.9
Table 3 Ranking of the predictors of polypharmacy by
their overall discriminatory power
Independent variable Power
Total number of diagnoses per patient on a single visit 100.0
Ownership of health facility (public/private) 36.1
Patient treated with artemether lumefantrine 26.8
Health worker age 26.0
Patient seen by health worker with IMCI training 16.1
No stockouts of artemether lumefantrine in previous 90 days 13.9
Health worker sex 12.1
Patient seen by health worker supervised within previous six months 11.5
Transmission season 4.8
Availability of any scale in the health facility 4.5
Patient seen by health worker with experience on caring patients 3.9
Supplies to administer oral medications 2.4
Type of health facility 1.0
Health workers' cadre 0.4
Any artemether lumefantrine available in health facility today 0.1
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The difference in discriminatory power between the top
predictor variable and the next most important predictor
was substantial (100% vs 36.1%). Similar results are
obtained by the classification tree model (Figure 1).
Patients diagnosed with more than one disease on a
single attendance had higher chances of being prescribed
three or more medicines: 69.6% (compared to 32.1% in
those with one diagnosis). The next most important fac-
tor among patients with more than one diagnosis was
supervision of health worker within the previous six
months where polypharmacy occurred in 77.2% patients
treated by an unsupervised health worker as compared
to 52% in those treated by a supervised health worker
(p-value<0.0001). For patients with one diagnosis, the
next splitting factor was being treated with AL whereby
more than three drugs were prescribed to 43% of
patients treated with AL compared to 27.3% of those not
treated with AL. Looking further at patients with one
diagnosis and treated with AL, those treated in a facility
that did not experience AL stock-out in the previous
three months were more likely to be given more than
three drugs (48%) compared to 25% of those served in
clinics that experienced AL stock outs in the previous
three months but this difference was not significant
Figure 1 Classification tree representing the predictors of polypharmacy prevalence. Note: Inside the boxes (nodes); Yes = Greater or
equal to three drugs (Polypharmacy), No = Less than three drugs.
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(p-value = 0.124). In patients with one diagnosis not
treated with AL, ownership of facility was the next split-
ting factor where those served in privately owned facil-
ities were more likely to receive three or more drugs
compared to those in public facilities (47% vs 22.2%) and
this was statistically significant (p-value = 0.003). Over-
all, the classification tree for polypharmacy (Figure 1)
had a sensitivity of 67% and a specificity of 66%. Health
worker’s age and training in Integrated Management of
Childhood Illnesses (IMCI) may not have appeared in
the classification tree as main splitters but are important
variables as shown by their overall discriminatory power
of 26% and 16.1% respectively (Table 3).
Co-prescription of antibiotics with artemether-lumefantrine
Overall, 84.7% (n = 1,233) of the patients interviewed had
more than one treatment with a median number of two
prescribed medications per patient-clinic visit (range 1–6).
Among the 508 (34.9%) patients treated with AL, the most
commonly prescribed concomitant medications were
analgesics (87.4%, n = 445), followed by antibiotics (41.6%,
n = 212) and other medications (31.6%, n = 161). Accord-
ing to the overall discriminatory power from the classifica-
tion tree analysis, patient age emerged as the strongest
overall risk factor for co-prescription of AL with an anti-
biotic, closely followed by the season of the interview
(power: 93%), mode of diagnosis (power: 90%), availability
of national malaria guideline (power: 84.5%) (Table 4).
Classification tree modelling for co-prescription of
artemether-lumefantrine with antibiotics
The classification tree partitioned the predictors according
to the overall discriminatory power of variables (Figure 2).
In modelling the co-prescription of AL with antibiotics,
patient clinical status (number of diagnoses) was found
to be very important and when included in the model it
masked the effect of other variables. For that reason it
was deliberately removed so as to examine and assess
the importance of other factors which may not be as
obvious. The classification tree for co-prescription of AL
with antibiotics has the most important predictors as
patient age, transmission season, mode of diagnosis and
location of health facility in terms of HDSS. Co-
prescription of AL with antibiotics was done for 41.7%
of the patients visiting the clinics during the study
period. This was common among patients aged less than
five years, at 47.9% compared to 35.2% of those aged
five years and above. For the older patients (≥5 year),
this co-prescription was common in those treated after
being tested for malaria (42.1%) compared to those pre-
sumptively treated (28.6%), though the difference was
not statistically significant (P-value = 0.1471). In the
under fives, co-prescription occurred more frequently
during the high (55.6%) than in the low malaria
transmission season (38.5%). The location of the facility
was important whereby patients treated in the high mal-
aria transmission season at a facility in the Ifakara HDSS
catchment area were more likely to be co-prescribed
with AL and an antibiotic (62.5%) than those served in
Rufiji HDSS catchment area (46.9%) (P-value = 0.0086).
Some variables did not appear as main splitters in the
tree despite their overall high discriminatory power
(Table 4). This is due to the fact that they are important
at several stages of the classification building tree but
never as important as the main splitter.
Discussion
The first step to improve the rational use of drugs is to
understand prescribing patterns. This paper demonstrates
the application of classification tree analysis models a
non-parametric modelling methodology to explore factors
influencing drug prescription practices in health facilities
of rural Tanzania. Classification trees are user friendly and
easy to interpret and have been utilized to identify the
main risk factors for malaria infection in Burundi and
Vietnam [21,23]. In this analysis, the classification tree
method revealed logical results of the relationships be-
tween the outcomes of interest (polypharmacy and co-
prescription of AL with antibiotics) and the predictor
variables.
While multinomial models reveal factors that predict
the outcome in the whole population, classification
tree analysis helps in detecting population segments
that need specific attention in relation to the outcome.
Segmenting populations supports decision makers in
targeting their efforts to specific subgroups. It is
Table 4 Ranking the predictors of co-prescription of
artemether-lumefantrine with antibiotics
Independent variable Power
Age group of the patients 100.0
Transmission season 92.6
Mode of diagnosis 90.4
Possession of national malaria guideline 84.5
Possession of job aids 78.7
Patient seen by health worker with IMCI training 77.6
Patient seen by health worker supervised within previous six months 67.0
Patient seen by health worker with experience 40.2
Patient seen health worker who trained on use of new anti-malarial 36.8
Health worker sex 32.3
Possession of national malaria wall chart 26.9
Health worker age 18.9
Health workers' cadre 10.6
Patient seen by health worker with medical training 9.1
Ownership of health facility (public/private) 8.6
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important to note that this analysis does not support
any claim of superiority of one methodology compared
to the other.
This analysis demonstrated some real-life treatment
practices at the facilities. It is common for most patients
to report with more than one complaint, which compels
the health worker to prescribe more than one medica-
tion for each identified illness. The IMCI strategy was
introduced by WHO to reduce child morbidity and
mortality. Indeed, treatment of childhood illness may
also be complicated by the need to combine therapy for
several conditions [25]. It is therefore not surprising that
the total number of diagnoses was the most important
predictor of polypharmacy as revealed by both its rank-
ing in terms of importance and being a major splitter in
the classification tree. A plausible explanation is that
health workers are insecure about the diagnosis since in
most cases the available laboratory services are unable to
Figure 2 Classification tree representing the predictors of co-prescription of artemether-lumefantrine (First line drug) with an
antibiotic. Note: Inside the boxes (nodes); Yes = Co-prescription of AL with antibiotics, No = No co-prescription of AL with antibiotics.
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accurately determine the cause of illness. Therefore, to
satisfy the patients, the health worker prescribes more
drugs and then justifies this practice by diagnosing sev-
eral pathological conditions.
Supervision of health workers is another important
predictor of polypharmacy. Indeed, polypharmacy was
more common among unsupervised health workers. It is
worth noting that this study did not comprehensively ex-
plore the type of supervision, limiting the conclusions
on the possible consequences of not having adequate
supervision on prescription practices. Nonetheless, it
would be advisable for district health authorities to in-
clude drug prescription practices during their routine
supervision visits.
Polypharmacy is common in the private sector where
individual motivation and incentives may have prepon-
derance over the knowledge and skills of the providers.
Health worker age, sex, being trained in IMICI and
being supervised in previous six months were the health
worker-related variables identified as the other import-
ant variables that explain polypharmacy. The observa-
tion that patients treated with AL in a clinic that did not
experience stock-outs of artemether-lumefantrine are
more likely to be prescribed several treatments is
expected and could be due to the IMCI strategy, which
recommends this practice, especially for children pre-
senting with multiple symptoms.
In general, presumptive diagnosis was common in
public facilities while laboratory results were more used
in privately owned facilities. In SSA, it is common prac-
tice not to use the test result when treating fever cases
[26]. The practice of presumptive treatment for malaria
has been and is still being practiced in several health fa-
cilities, both in rural- and urban-based centres, because
the syndromic treatment for febrile illnesses has been
standard practice for long time, and clinicians mistrust
the laboratory results due to poor quality of the labora-
tory tests. Patients with a negative malaria test are still
treated with an anti-malarial on the grounds that signs
and symptoms are compatible with the diagnosis of mal-
aria. This continues even after the introduction of mal-
aria rapid diagnostic tests. [26]
The recommended first-line anti-malarial drug (AL)
was more commonly used in public than in private facil-
ities as the former are supplied with essential drugs dir-
ectly by the central pharmacy. This may change with the
introduction of the Affordable Medicine Facility for mal-
aria (AMFm) strategy in Tanzania whose approach is to
supply subsidized AL to the private sector [27]. It will
therefore be interesting to look at how these changes in
the health system will affect the prescription patterns in
Tanzania and other African countries over time.
There was a high level of co-prescription of antibiotics
with AL, particularly in children less than five years
living around the Ifakara area. A study in Ghana con-
ducted predominantly in government facilities in an
urban setting showed that 30.8% of patients were receiv-
ing at least one antibiotic in addition to the recom-
mended anti-malarial [28]. Co-prescription with
antibiotics is a life saving practice and commonly prac-
ticed in health facilities in sub-Saharan Africa since
patients can present with multiple illnesses at a single
clinic visit. This is why it was promoted under the IMCI
strategy. However, this has implications for the patient’s
safety as it may increase the risk of drug-drug interac-
tions (D-DI), therapeutic failure, drug resistance and ad-
verse events [29]. If this practice of co-prescription of
drugs, which is common in rural health facilities, is not
addressed, it may cause a major problem as the risk of
adverse drug events (ADE) increases with an increasing
number of medicines prescribed [30-33].
Classification tree analysis models are useful in
expressing relationships between variables since they do
not need to be linear or additive and the possible inter-
actions do not need to be pre-specified or of a particu-
lar multiplicative form. Results are presented in the
form of a decision tree, a different approach than the
standard statistical analysis. The results highlight areas
that merit further attention and can act as a guide for
further epidemiological and hypothesis-driven research.
The classification trees provide a more flexible relation-
ship between variables; missing values of the covariates,
multi-colinearity and outliers are taken care of in an in-
tuitively and correct manner [19]. This methodology has
proven its usefulness and adequacy in other areas and
contexts, for example the bee colony collapse disorder,
bovine spongiform encephalopathy and analysis of urban
farming systems in central Africa [17,19,20]. In malaria,
this method has been used for ranking highland malaria
risk factors in Burundi and in Vietnam [21,23]. However,
it has a limitation of not providing p-values and standard
deviations as in familiar parametric methods. Another
limitation is that confounding values make classification
tasks more difficult. Although this decreases true positive
rates and accuracies, the constructed classification trees
are valuable. The benefit of the trees is that they simulate
more the real life situation with patients who have con-
founding attributes. Future work should be aimed at
finding different ways to handle confounding values in
the reasoning process. Another advantage is that the im-
portance of the variable can still be seen in the variable
relative importance.
A variable may be ranked among the top ones for the
discriminatory power but may not appear as an important
splitter in the classification tree, e g, training in IMCI with
anti-malarial component. This happens because it is an
important surrogate but not a major splitter. The ranking
by overall discriminatory power is determined by the sum
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across all nodes in the tree of the improvement score that
the predictor has when it acts as a primary or a surrogate
splitter. Consequently, a health worker having IMCI train-
ing with anti-malarial component enters the tree as the
top surrogate splitter in many nodes but never as primary
splitter.
Initiatives like the INESS Phase IV platform, working
within communities through the HDSS system should
continue to evaluate the effect of provider practice on
new and old products and may be extended to other
therapeutic areas such as ARVs, anti-TBs, antibiotics
and vaccines. Inclusion of the private sector, e g, private
pharmacies, retail shops, mobile drug sellers and even
traditional herbalists will provide public health managers
with more evidence on which to base their decisions.
Conclusions
The classification tree analysis approach can be used to
classify prescription patterns using health facility informa-
tion. This procedure offers an opportunity to examine alter-
native methods of identifying predictors of prescription
patterns that might assist decision makers to improve
targeted service provision factors. This study has demon-
strated that polypharmacy is mainly associated with mul-
tiple diagnoses while co-prescription of AL with antibiotics
is mainly associated with patient age. Although these are
considered life saving practices, they expose patients to risks
of adverse drug reactions. Bacterial antibiotic resistance
should be looked as a public health emergency and the two
competing causes of increased bacterial resistance are
irrational antibiotic use and availability of poor quality anti-
biotics. Drug prescription practices may improve by intro-
ducing targeted interventions such as regular supervision of
health care providers in both public and private health
facilities.
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